To fulfill FDA informed consent requirements for studies of IVDs, a site may develop an informed consent process to address the use of samples collected at the facility in a specific study or for a broader category of future studies. This general informed consent process may be used for subjects seen at and/or admitted to a specific facility. The informed consent document must contain all of the required elements found in 21 CFR 50.25.